XIT Corp formerly GSR III Acquisition Corp is a United States-based company. The Company is a wholly owned subsidiary of Terra Innovatum Global N.V. The Company is not engaged in any business activities. The Company has no revenue.

Employees

Sector

Investment Holding Companies

More about the company

Quotes

Date	Price	Change	Volume
11/09/26	US$5.110	-2.67%	132,461
10/09/26	US$5.250	-3.67%	140,087
09/09/26	US$5.450	-3.71%	155,175
08/09/26	US$5.660	+7.40%	263,997
04/09/26	US$5.270	+4.98%	280,477

Delayed Quote Nasdaq

More quotes

Market Closed - Nasdaq 21:00:00 11/09/2026 BST			5-day change	1st Jan Change
5.110 ^USD	-2.67%		-3.04%	-67.07%

11-17	GSR III Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
10/10/25	Terra Innovatum Global Completes Business Combination With GSR III Acquisition	MT

Market Cap	453M 390M 369M 335M 628M 43.25B 631M 4.39B 1.69B 22.01B 1.7B 1.66B 69.54B	P/E 2023 *	-	P/E 2024	95.2x
Enterprise Value	451M 389M 368M 333M 626M 43.08B 629M 4.37B 1.68B 21.92B 1.69B 1.66B 69.26B	EV / Sales 2023 *	-	EV / Sales 2024	-
Free-Float	16.3%	Yield 2023 *	-	Yield 2024	-

11-17	GSR III Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
10/10/25	Terra Innovatum Global Completes Business Combination With GSR III Acquisition	MT
09/10/25	Terra Innovatum to begin trading on Nasdaq under the symbol "NKLR"	RE
08/10/25	GSR III Acquisition Corp.(NasdaqGM:GSRT) dropped from NASDAQ Composite Index	CI
08/10/25	Terra Innovatum s.r.l. completed the acquisition of GSR III Acquisition Corp. from GSR III Sponsor LLC and others in a reverse merger transaction.	CI
07/10/25	GSR III Acquisition Shareholders Approve Merger With Terra	MT
30/09/25	Terra Innovatum Announces Strategic Alliance with Defense Engineering Center, RAIT 88, to Accelerate Global Commercialization of SOLO?? Micro-Modular Nuclear Reactors	CI
29/09/25	Ameresco Signs MOU With GSR III, Terra Innovatum to Deploy Reactor Units	MT
29/09/25	Terra Innovatum signs MoU with Ameresco	RE
29/09/25	Terra Innovatum Partners with Ameresco to Jointly Pursue Public-Private Commercial Opportunities in the U.S. and Global Markets to Deploy SOLO Micro-Modular Reactor	CI
25/09/25	GSR III Acquisition, Terra Innovatum Secure $37.5 Million Equity Financing for Business Combination	MT
23/09/25	Roth Capital Initiates GSR III Acquisition Corp at Buy	MT
22/09/25	GSR III Acquisition Corp. announced that it expects to receive $31.84 million in funding	CI

23/09/25	Roth Capital Initiates GSR III Acquisition Corp at Buy	MT
12/08/25	Benchmark Initiates GSR III Acquisition at Buy With $19 Price Target	MT

GSR IIIPAR Share Price

Stocks

GSRT

KYG4R1031072

Investment Holding Companies

Valuation : GSR IIIPAR

Chart: GSR IIIPAR

Latest news : GSR IIIPAR

Analysts' recommendations : GSR IIIPAR

Press Releases : GSR IIIPAR

Quotes and Performance

Price Extremes

Latest insider transactions

Shell Companies

Financials

Company Profile

Quotes

30/09/25	Terra Innovatum and GSR III Acquisition Corp. Remind Shareholders to Vote and Approve the Business Combination Prior to the October 7 Extraordinary General Meeting of Shareholders	AQ
22/09/25	Terra Innovatum Advances U.S. NRC Licensing Process with Accelerated Regulatory Submissions for SOLO™ Reactor	AQ
16/09/25	Terra Innovatum Signs Supplier MOU with Conuar for Key SOLO Micro-Modular Reactor Components	AQ
15/09/25	Terra Innovatum and GSR III Acquisition Corp. Announce Effectiveness of S-4 and Set Extraordinary General Meeting Date to Approve Business Combination	AQ
09/09/25	TerraInnovatum Partners with ATB Riva Calzoni for Manufacturing of SOLO Micro-Modular Nuclear Reactor	AQ

1 year	5.1	15.62
3 years	5.1	15.62
5 years	5.1	15.62
10 years	5.1	15.62

Date	Insider	Type	Main position	Quantity	% Market Cap.
16/10/25	Massimo Morichi	Conversion	See remarks; Director	360	4.4776%
16/10/25	Giordano Morichi	Conversion	See remarks	320	3.9801%
16/10/25	Guillaume Moyen	Conversion	Chief Financial Officer; Director	20	0.2488%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GSR IIIPAR	-2.67%	-3.04%	-50.91%	-	453M
CHURCHILL CAPITAL CORP XI	-3.83%	-8.06%	-	-	686M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	-0.07%	-0.07%	-	-	647M
BAIN CAPITAL GSS INVESTMENT CORP.	-0.10%	-0.24%	-	-	601M
CHURCHILL CAPITAL CORP XII	+0.46%	+0.65%	-	-	599M
CANTOR EQUITY PARTNERS IV, INC.	0.00%	-0.43%	+1.92%	-	592M
CENTIEL AG	+1.75%	+3.93%	+257.49%	-77.95%	582M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.70%	-0.96%	-	-	559M
CHURCHILL CAPITAL CORP XIII	+0.76%	+0.66%	-	-	513M
Average	-0.49%	-0.84%	+69.50%	-77.95%	581.27M
Weighted average by Cap.	-0.51%	-0.93%	+78.68%	-77.95%

	2023	2024
Net sales	-	-
Net income	-24.75K -21.32K -20.19K -18.3K -34.33K -2.36M -34.5K -240K -92.21K -1.2M -92.94K -90.9K -3.8M	949K 818K 774K 702K 1.32M 90.69M 1.32M 9.2M 3.54M 46.14M 3.57M 3.49M 146M
Net Debt	-	-1.79 -1.54 -1.46 -1.32 -2.48 -170.72 -2.49 -17.32 -6.66 -86.86 -6.71 -6.56 -274.46

1 day	-2.67%
Current month	-67.07%
Current year	-67.07%